Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain
NCT: NCT06717789 · COMPLETED
Brief Summary
This post-market clinical study of the SP8.0 Compex device aims to comprehensively assess the safety and performance of the device when used in accordance with the approved Instructions for Use. The results of this study will also support the clinical evaluation of the next-generation wireless product currently under development. The Compex Consumer devices contain different programs, such as conditioning, fitness, recovery, massage, rehabilitation, and pain management. This study will utilize the Compex SP 8.0 pain management programs, with the aim of assessing the effectiveness of the treatment provided by the device in managing pain through different physiological mechanisms.
Frequently Asked Questions
What is Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain?
Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain is a clinical trial registered under NCT06717789. Current status: COMPLETED.
What is the status of NCT06717789?
The current status of NCT06717789 (Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain) is: COMPLETED.
When did Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain start?
Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain started on 2025-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.